Photocure (0IMT)

Currency in NOK
60.80
+8.30(+15.81%)
Closed·
0IMT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
0IMT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
60.8060.80
52 wk Range
48.0069.80
Key Statistics
Prev. Close
52.5
Open
60.8
Day's Range
60.8-60.8
52 wk Range
48-69.8
Volume
14.03K
Average Volume (3m)
1.4K
1-Year Change
21.19%
Book Value / Share
18.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0IMT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Photocure News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Photocure Company Profile

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreement with Richard Wolf GmbH to develop and commercialize a 4K LED high-definition reusable blue light cystoscope based on Richard Wolf’s System blue technology. It sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. The company operates in the Nordic countries, Germany, France, Austria, the United Kingdom, the Benelux, Italy, rest of the Europe, Canada, and the United States. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.

Employees
100

Compare 0IMT to Peers and Sector

Metrics to compare
0IMT
Peers
Sector
Relationship
P/E Ratio
−301.0x−0.1x−0.5x
PEG Ratio
2.120.020.00
Price/Book
3.3x2.2x2.6x
Price / LTM Sales
3.1x1.4x3.3x
Upside (Analyst Target)
-40.1%43.4%
Fair Value Upside
Unlock9.2%7.1%Unlock

Earnings

Latest Release
Jul 30, 2025
EPS / Forecast
-0.06 / 0.02
Revenue / Forecast
135.80M / 130.70M
EPS Revisions
Last 90 days

0IMT Income Statement

FAQ

What Stock Exchange Does Photocure Trade On?

Photocure is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Photocure?

The stock symbol for Photocure is "0IMT."

What Is the Photocure Market Cap?

As of today, Photocure market cap is 1.63B.

What Is Photocure's Earnings Per Share (TTM)?

The Photocure EPS (TTM) is -0.20.

When Is the Next Photocure Earnings Date?

Photocure will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is 0IMT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Photocure Stock Split?

Photocure has split 0 times.

How Many Employees Does Photocure Have?

Photocure has 100 employees.

What is the current trading status of Photocure (0IMT)?

As of 08 Aug 2025, Photocure (0IMT) is trading at a price of 60.80, with a previous close of 52.50. The stock has fluctuated within a day range of 60.80 to 60.80, while its 52-week range spans from 48.00 to 69.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.